Your browser doesn't support javascript.
loading
CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus.
Textor, Ana; Grunewald, Laura; Anders, Kathleen; Klaus, Anika; Schwiebert, Silke; Winkler, Annika; Stecklum, Maria; Rolff, Jana; Henssen, Anton G; Höpken, Uta E; Eggert, Angelika; Schulte, Johannes H; Jensen, Michael C; Blankenstein, Thomas; Künkele, Annette.
Afiliación
  • Textor A; Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13092 Berlin, Germany.
  • Grunewald L; Institute of Immunology, Charité Campus Buch, 13092 Berlin, Germany.
  • Anders K; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Klaus A; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
  • Schwiebert S; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
  • Winkler A; German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), 10178 Berlin, Germany.
  • Stecklum M; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
  • Rolff J; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
  • Henssen AG; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
  • Höpken UE; Experimental Pharmacology & Oncology Berlin Buch, 13125 Berlin, Germany.
  • Eggert A; Experimental Pharmacology & Oncology Berlin Buch, 13125 Berlin, Germany.
  • Schulte JH; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
  • Jensen MC; Experimental and Clinical Research Center, Lindenberger Weg 80, 13125 Berlin, Germany.
  • Blankenstein T; Berlin Institute of Health (BIH), 10178 Berlin, Germany.
  • Künkele A; Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13092 Berlin, Germany.
Cancers (Basel) ; 13(5)2021 Mar 02.
Article en En | MEDLINE | ID: mdl-33801448
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza